Center-Authored Papers
Filters: Keyword is Estrogens [Clear All Filters]
Daidzein-metabolizing phenotypes in relation to serum hormones and sex hormone binding globulin, and urinary estrogen metabolites in premenopausal women in the United States.. Cancer causes & control : CCC. 19(10):1085-93. Abstract
.
2008.
Effect of hormone therapy on lean body mass, falls, and fractures: 6-year results from the Women's Health Initiative hormone trials.. Menopause (New York, N.Y.). 18(1):44-52. Abstract
.
2011.
Usefulness of baseline lipids and C-reactive protein in women receiving menopausal hormone therapy as predictors of treatment-related coronary events.. The American journal of cardiology. 101(11):1599-1605. Abstract
.
2008.
Hormone therapy improves femur geometry among ethnically diverse postmenopausal participants in the Women's Health Initiative hormone intervention trials.. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 23(12):1935-45. Abstract
.
2008.
Menopausal hormone therapy in BRCA1 mutation carriers: uncertainty and caution.. Journal of the National Cancer Institute. 100(19):1341-3.
.
2008.
Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy.. Archives of internal medicine. 168(4):370-7;quiz345. Abstract
.
2008.
Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(7):1751-9. Abstract
.
2008.
The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women.. Menopause (New York, N.Y.). 17(3):622-9. Abstract
.
2010.
Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history.. American journal of epidemiology. 168(6):563-70;discussion571-6. Abstract
.
2008.
Endometrial hyperplasia risk in relation to recent use of oral contraceptives and hormone therapy.. Annals of epidemiology. 19(1):1-7. Abstract
.
2009.
Frequent intentional weight loss is associated with higher ghrelin and lower glucose and androgen levels in postmenopausal women.. Nutrition research (New York, N.Y.). 30(3):163-70. Abstract
.
2010.
Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial.. JAMA : the journal of the American Medical Association. 305(13):1305-14. Abstract
.
2011.
Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(1):43-50. Abstract
.
2008.
Postmenopausal hormone use and the risk of nephrolithiasis: results from the Women's Health Initiative hormone therapy trials.. Archives of internal medicine. 170(18):1678-85. Abstract
.
2010.
Hormone therapy use and outcomes in the Women's Health Initiative trials--reply.. JAMA : the journal of the American Medical Association. 311(4):417-8.
.
2014.
Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.. JAMA : the journal of the American Medical Association. 310(13):1353-68. Abstract
.
2013.
Detection of elevated plasma levels of epidermal growth factor receptor before breast cancer diagnosis among hormone therapy users.. Cancer research. 70(21):8598-606. Abstract
.
2010.
Confounding effects of hormone replacement therapy in protein biomarker studies.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(1):134-9. Abstract
.
2011.
Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study.. American journal of epidemiology. 167(12):1407-15. Abstract
.
2008.
Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.. American journal of epidemiology. 170(1):12-23. Abstract
.
2009.
Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(11):3079-85. Abstract
.
2009.
Data analysis methods and the reliability of analytic epidemiologic research.. Epidemiology (Cambridge, Mass.). 19(6):785-8;discussion789-93. Abstract
.
2008.
Age-related variation in the relationship between menopausal hormone therapy and the risk of dying from breast cancer.. Breast cancer research and treatment. 126(3):749-61. Abstract
.
2011.
Cardiovascular risk in women with non-specific chest pain (from the Women's Health Initiative Hormone Trials).. The American journal of cardiology. 102(6):693-9. Abstract
.
2008.
Estrogen plus progestin and risk of benign proliferative breast disease.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(9):2337-43. Abstract
.
2008. Doing Business with Arnold Library
Weintraub Building, B1-010
(206) 667-4314
library@fredhutch.org
More About Arnold Library
Quick Links
- ILLiad/ILL Form
- Journals List
- Ovid - Medline
- Web of Science
- Pubmed
- Libguides
- Library Catalog
- Researcher Profiles
- Library Affiliations & Memberships
- Fred Hutch Papers (Intranet)